Interactive Brokers Advertisement
Home > Boards > US Listed > Biotechs >

Charles River Laboratories International, Inc. (CRL)

Add CRL Price Alert      Hide Sticky   Hide Intro
Search This Board: 
Last Post: 1/4/2017 9:44:00 AM - Followers: 1 - Board type: Free - Posts Today: 0

Charles River Laboratories International, Inc. 251 Ballardvale Street Wilmington, MA 01887 United States - Map Phone: 781-222-6000 Fax: 978-988-9236 Website: Details Index Membership: S&P 400 MidCap S&P 1500 Super Comp Sector: Healthcare Industry: Biotechnology Full Time Employees: 8,000 Business Summary Charles River Laboratories International, Inc. provides research models and laboratory animal support expertise to help its global partners advance their research and drug development efforts. The company offers a portfolio of services to support discovery and imaging, preclinical and early-phase clinical studies, and biopharmaceutical and endotoxin products and services for manufacturing and quality control. Its portfolio spans the entire research and drug development process, from IND consultation to discovery through market approval, allowing customized approaches to support both single-study or broad-based programs. Charles River Laboratories International serves pharmaceutical and biotechnology companies, as well as government agencies, hospitals, and academic institutions. The company was founded in 1947 and is headquartered in Wilmington, Massachusetts.
Interactive Brokers Advertisement
Current Price
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
CRL News: Quarterly Report (10-q) 11/09/2017 10:10:22 AM
CRL News: Current Report Filing (8-k) 11/09/2017 07:31:48 AM
CRL News: Charles River Laboratories Announces Third-Quarter 2017 Results from Continuing Operations 11/09/2017 07:00:00 AM
CRL News: Charles River Announces Expansion of In Vitro Oncology Services 10/26/2017 08:00:00 AM
CRL News: Charles River Laboratories Changes the Date of Its Third-Quarter 2017 Earnings Release and Conference Call 10/12/2017 04:30:00 PM